Ticagrelor is a promising drug for the effective treatment of ACS. When using ticagrelor, individualized treatment should be provided based on the specific conditions of the patients to avoid serious adverse events.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- end stage renal disease
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- chronic kidney disease
- ejection fraction
- newly diagnosed
- emergency department
- prognostic factors
- peritoneal dialysis
- atrial fibrillation
- adverse drug